REQUEST A DEMO
Total
USD $0.00
Search more companies

M.S. Ally Pharma Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: M.S. Ally Pharma Sdn. Bhd. Profile Updated: October 16, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2018 Available in: English Download a sample report

M.S. Ally Pharma Sdn. Bhd. is a company based in Malaysia, with its head office in Kuala Lumpur. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. M.S. Ally Pharma Sdn. Bhd. was incorporated on March 12, 1999. In its most recent financial highlights, the company reported a net sales revenue increase of 27.32% in 2018. There was a total growth of 4.57% in M.S. Ally Pharma Sdn. Bhd.’s total assets over the same period. The net profit margin of M.S. Ally Pharma Sdn. Bhd. increased by 0.24% in 2018.

Headquarters
No.43-2A,Jalan Thambapillai, Brickfields, Kuala Lumpur
Kuala Lumpur; Federal Territories; Postal Code: 50470

Contact Details: Purchase the M.S. Ally Pharma Sdn. Bhd. report to view the information.

Basic Information
Registered Capital:
Purchase the M.S. Ally Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the M.S. Ally Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
March 12, 1999
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after M.S. Ally Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
27.32%
Total operating revenue
27.32%
Net Profit (Loss) for the Period
73.95%
Total assets
4.57%
Total equity
20.24%
Net Profit Margin
0.24%
Return on Equity (ROE)
6.63%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?